PCL, Inc.
KOSDAQ 241820.KQ
PCL, Inc. Shares (Diluted, Weighted) for the year ending December 31, 2023: 40,615,086
-
PCL, Inc. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 35,428,595, a 4.04% change year over year.
-
PCL, Inc. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 34,054,479, a 0.06% change year over year.
-
PCL, Inc. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 34,035,097, a 11.97% change year over year.
-
PCL, Inc. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 30,397,552, a 1.18% change year over year.
| Date | Shares (Diluted, Weighted) | Revenue | Cost of Revenue | Gross Profit |
|---|
| CEO | Ms. Soyeon Kim |
| IPO Date | Feb. 23, 2017 |
| Location | South Korea |
| Headquarters | Star valley, 99 |
| Employees | 31 |
| Sector | Health Care |
| Industries | |
PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers multiplex antibody and antigen diagnostic kits for the detection of antibodies to human immunodeficiency virus (HIV) 1 and 2, HBV, hepatitis C virus (HCV), and human T-lymphotropic virus 1 and 2, as well as antigens to HIV p24, HCV core, and HBV surface in human serum or plasma. It also provides Ai, an influenza A/B typing rapid diagnostic test kit; Cancer6, a multiple tumor markers screening kit; and sciLINER LATERAL FLOW DISPENSER, a dispenser for membrane materials with active visual drop volume control. In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified. PCL, Inc. is headquartered in Seoul, South Korea.
Past 5 years
USD 17.02
USD 7.85
USD 11.69
StockViz Staff
January 15, 2025
Any question? Send us an email